The Traderszone Network

Published in TZ Latest News 24 March, 2016 by The TZ Newswire Staff

Portola Pharmaceuticals’ Betrixaban Misses Mark, But All Is Not Lost

Betrixaban delivers a clinical benefit, but statistical significance is murky in one key group.